Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 13.


Davison, Andrew S ORCID: 0000-0001-5501-4475, Strittmatter, N, Sutherland, H, Hughes, AT, Hughes, J, Bou-Gharios, G ORCID: 0000-0002-9563-9418, Milan, AM, Goodwin, RJA, Ranganath, LR and Gallagher, JA ORCID: 0000-0002-0852-279X
(2019) Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging (vol 15, 68, 2019). METABOLOMICS, 15 (5).


Davison, Andrew S ORCID: 0000-0001-5501-4475, Strittmatter, N, Sutherland, H, Hughes, AT, Hughes, J ORCID: 0000-0001-6155-4136, Bou-Gharios, G, Milan, AM ORCID: 0000-0002-0452-2338, Goodwin, RJA, Ranganath, LR and Gallagher, JA ORCID: 0000-0002-0852-279X
(2019) Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging. Metabolomics : Official journal of the Metabolomic Society, 15 (5). p. 68.


Davison, AS ORCID: 0000-0001-5501-4475, Norman, B ORCID: 0000-0001-9293-4852, Milan, AM ORCID: 0000-0002-0452-2338, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Rovensky, J, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR
(2018) Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment. JIMD REPORTS: FOCUS ISSUE: ADULTS AND METABOLISM, VOL 41, 41. pp. 1-10.


Khedr, M ORCID: 0000-0002-4998-2397, Judd, S, Briggs, MC, Hughes, AT, Milan, AM ORCID: 0000-0002-0452-2338, Stewart, RMK, Lock, EA, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR
(2018) Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria. JIMD REPORTS, VOL 40, 40. pp. 31-37.


Ranganath, LR, Milan, AM, Hughes, AT, Davison, AS ORCID: 0000-0001-5501-4475, Khedr, M, Norman, BP ORCID: 0000-0001-9293-4852, Bou-Gharios, G, Gallagher, JA ORCID: 0000-0002-0852-279X, Gornall, M, Jackson, R
et al (show 4 more authors) (2022) Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria. Molecular Genetics and Metabolism Reports, 30. p. 100846.


Davison, AS ORCID: 0000-0001-5501-4475, Harrold, JA ORCID: 0000-0002-0899-4586, Hughes, G, Norman, B ORCID: 0000-0001-9293-4852, Devine, J, Usher, J, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Gallagher, JA ORCID: 0000-0002-0852-279X, Milan, AM ORCID: 0000-0002-0452-2338
et al (show 2 more authors) (2018) Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone. Molecular Genetics and Metabolism, 125 (1-2). pp. 135-143.


Griffin, R ORCID: 0000-0003-4521-948X, Psarelli, EE ORCID: 0000-0002-3102-0288, Cox, TF, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Davison, AS ORCID: 0000-0001-5501-4475, Hughes, AT, Usher, JL, Taylor, S, Loftus, N
et al (show 17 more authors) (2018) Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone. Data in Brief, 20. pp. 1620-1628.


Ranganath, LR, Milan, AM, Hughes, AT, Davison, AS, Khedr, M, Norman, BP, Bou-Gharios, G, Gallagher, JA, Imrich, R, Arnoux, JB
et al (show 2 more authors) (2022) Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria. SCIENTIFIC REPORTS, 12 (1). 16083-.


Hughes, JH ORCID: 0000-0001-6155-4136, Liu, K, Sutherland, H, Wilson, PJ, Hughes, AT, Milan, AM ORCID: 0000-0002-0452-2338, Ranganath, LR, Gallagher, JA ORCID: 0000-0002-0852-279X and Bou-Gharios, G
(2018) GENERATION AND PHENOTYPING OF A TARGETED MOUSE MODEL OF ALKAPTONURIA. .


Ranganath, LR, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Davison, AS ORCID: 0000-0001-5501-4475, Hughes, AT, Usher, JL, Taylor, S, Loftus, N, Daroszewska, A ORCID: 0000-0002-6692-6610, West, E
et al (show 17 more authors) (2018) Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre. Molecular genetics and metabolism, 125 (1-2). pp. 127-134.


Milan, AM ORCID: 0000-0002-0452-2338, Hughes, AT, Davison, AS ORCID: 0000-0001-5501-4475, Khedr, M ORCID: 0000-0002-4998-2397, Rovensky, J, Psarelli, EE ORCID: 0000-0002-3102-0288, Cox, TF, Rhodes, NP ORCID: 0000-0002-5173-7032, Gallagher, JA and Ranganath, LR
(2019) Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria. SCIENTIFIC REPORTS, 9 (1). 10024-.


Davison, AS ORCID: 0000-0001-5501-4475, Norman, BP ORCID: 0000-0001-9293-4852, Smith, EA, Devine, J, Usher, J, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR
(2018) Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone. JIMD REPORTS: FOCUS ISSUE: ADULTS AND METABOLISM, VOL 41, 41. pp. 109-117.


Ranganath, LR, Hughes, AT, Davison, AS, Khedr, M, Olsson, B, Rudebeck, M, Imrich, R, Norman, BP ORCID: 0000-0001-9293-4852, Bou-Gharios, G, Gallagher, JA ORCID: 0000-0002-0852-279X
et al (show 1 more authors) (2022) Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuria. Molecular genetics and metabolism. S1096-7192(22)00325-0-.

This list was generated on Mon Mar 11 00:56:38 2024 GMT.